Erika Smith
CEO​
business
Axerion Therapeutics
United States of America
Biography
More than 25 years of experience as an investor and entrepreneur in identifying, investing, managing and successfully exiting numerous seed and early-stage investments with funding from Yale and J & J.
Research Interest
investments with funding